Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matej Vicen"'
Autor:
Katarina Tripska, Ivone Cristina Igreja Sá, Martina Vasinova, Matej Vicen, Radim Havelek, Samira Eissazadeh, Zuzana Svobodova, Barbora Vitverova, Charles Theuer, Carmelo Bernabeu, Petr Nachtigal
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Endoglin (Eng) is a co-receptor of the transforming growth factor β superfamily playing an important role in endothelial dysfunction. TRC105 (carotuximab) is a monoclonal antibody that blocks Eng and its downstream Smad signaling pathway. Here we ha
Externí odkaz:
https://doaj.org/article/28fb14bd8fa6477fb7679a5ba2bb6b3c
Autor:
Barbora Vitverova, Iveta Najmanova, Matej Vicen, Katarina Tripska, Ivone Cristina Igreja Sa, Radek Hyspler, Miguel Pericacho, Petr Nachtigal
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233725 (2020)
Soluble endoglin (sEng) released into the circulation was suggested to be related to cardiovascular based pathologies. It was demonstrated that a combination of high sEng levels and long-term exposure (six months) to high fat diet (HFD) resulted in a
Externí odkaz:
https://doaj.org/article/c32f8442ccec4906854194457565070a
Autor:
Matej, Vicen, Barbora, Vitverova, Radim, Havelek, Katerina, Blazickova, Miloslav, Machacek, Jana, Rathouska, Iveta, Najmanová, Eva, Dolezelova, Alena, Prasnicka, Magdalena, Sternak, Carmelo, Bernabeu, Petr, Nachtigal
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 33(5)
Our objective was to investigate the effect of cholesterol [hypercholesterolemia and 7-ketocholesterol (7K)] on endoglin (Eng) expression and regulation with respect to endothelial or vascular dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57cd8d0405c97a657f335ce929d0d61c
https://pubmed.ncbi.nlm.nih.gov/30753095
https://pubmed.ncbi.nlm.nih.gov/30753095